Clinical Trial Update: Peak Inspiratory Flow and Dry Powder Inhaler Performance in COPD [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating peak inspiratory flow and dry powder inhaler performance in COPD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: Pulmonary Research Institute of Southeast Michigan | Conditions: COPD | Phase 4 | Status: COMPLETED | Results posted: 2023-05-08